ArticleScientific reports2021

Topoisomerase II alpha inhibition can overcome taxane-resistant prostate cancer through DNA repair pathways.

Hiroshi Hongo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.